**

Elanco Animal Health, a global leader in animal health innovation, announced today that its groundbreaking new cattle health product, TruCan®, has received approval from the United States Department of Agriculture (USDA). This significant milestone marks a pivotal moment for the livestock industry, promising enhanced cattle health, improved productivity, and a more sustainable approach to beef production. The approval of TruCan® signifies a major advancement in bovine health management, cattle disease prevention, and veterinary medicine.

TruCan®: A Revolutionary Approach to Cattle Health

TruCan®, a novel veterinary medicine product, represents a significant leap forward in controlling Mannheimia haemolytica, a bacterium responsible for bovine respiratory disease (BRD), a major cause of morbidity and mortality in cattle. BRD causes significant economic losses for cattle ranchers annually, impacting both animal welfare and profitability. Existing treatments often fall short, highlighting the need for innovative solutions like TruCan®. The approval of this product is a testament to Elanco's commitment to developing cutting-edge animal health solutions.

How TruCan® Works

TruCan® utilizes a unique mechanism of action, offering superior efficacy compared to traditional treatments. Unlike many other products, TruCan® provides:

• Targeted Action: It specifically targets Mannheimia haemolytica, minimizing the risk of disrupting the beneficial bacteria in the gut. This targeted approach helps maintain a healthy gut microbiome, crucial for overall cattle health and efficient feed conversion.
• Enhanced Efficacy: Clinical trials have demonstrated TruCan®'s superior efficacy in reducing the incidence and severity of BRD, leading to improved animal health and reduced mortality rates. This translates to significant improvements in cattle weight gain and overall productivity.
• Convenient Administration: Its administration method is designed for ease of use, minimizing stress on the animals and simplifying the process for ranchers and veterinarians. This aspect is crucial for efficient herd management and cost-effectiveness.
• Improved Disease Prevention: The preventative capabilities of TruCan® move beyond simply treating existing infections. Its formulation provides robust protection against future BRD outbreaks, offering long-term herd health benefits.

Impact on the Cattle Industry: A Sustainable Future

The implications of TruCan®'s approval extend beyond individual cattle producers. This advancement has the potential to significantly improve the sustainability of beef production. By reducing the need for repeated treatments and improving animal health, TruCan® contributes to:

• Reduced Antibiotic Use: The targeted action of TruCan® minimizes the need for broad-spectrum antibiotics, promoting responsible antibiotic stewardship and combatting antimicrobial resistance. This aligns with the growing global focus on reducing antibiotic use in livestock production. The product supports the ongoing efforts towards sustainable livestock farming and responsible animal husbandry practices.
• Improved Animal Welfare: healthier cattle leads to improved animal welfare. Reduced stress from illness and efficient treatment protocols directly benefit the animals' overall well-being. This is a crucial factor for consumers increasingly concerned about ethical and sustainable food production.
• Increased Profitability: Higher survival rates, improved weight gain, and reduced treatment costs translate directly into increased profitability for cattle ranchers. This economic advantage supports the long-term viability and sustainability of the beef industry.

TruCan® and the Future of Bovine Respiratory Disease Management

The USDA's approval of TruCan® represents a major breakthrough in the fight against BRD. This innovative product offers a superior solution compared to existing treatments, paving the way for improved cattle health, increased productivity, and a more sustainable future for the cattle industry. Elanco's commitment to research and development has resulted in a product with far-reaching implications for ranchers, veterinarians, and consumers alike.

What's Next for Elanco and TruCan®?

Elanco plans to make TruCan® widely available to cattle producers across the United States following its official launch. They are also investing in educational programs to ensure that veterinarians and producers are well-informed about the product's benefits and proper usage. The company will continue its commitment to research and development in the field of bovine health, working to further enhance animal health and welfare.

This pivotal moment in veterinary pharmacology highlights the importance of continued innovation in animal health. TruCan®'s approval is a testament to the transformative potential of advanced technologies in addressing critical challenges within the livestock sector. The product sets a new standard for BRD management, offering hope for a healthier, more productive, and more sustainable future for the beef industry. This success story also reinforces Elanco's position as a leading innovator in the field of animal health technology. The successful deployment of TruCan® will undoubtedly influence future developments in cattle health management and livestock disease control. Further research and development will likely focus on building on TruCan®’s success, potentially leading to the development of even more effective treatments for other prevalent cattle diseases.